© Drug Hunter Inc. 2018-2023
Home > LY3502970
oral non-peptide GLP-1R GPCR partial agonist
in Ph. I for Type 2 diabetes, HV study complete
from cell-based screen and opt.
PNAS, Nov. 11, 2020
Chugai, Shizuoka, JP / Eli Lilly, Indianapolis, IN
Chugai/Lilly clinical oral non-peptide GLP-1R GPCR partial agonist
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year